Semaglutide Wegovy / Ozempic Single GLP-1 receptor agonist
The numbers tell an impressive story: 67.8% of patients lost at least 5% of their weight, while 44.2% dropped 10% or more
Side Effects : In addition to the shared GLP-1 side effects above, increased heart rate, low blood sugar (especially in people with diabetes), and injection site reactions may also occur
Kilgour RD, Vigano A, Trutschnigg B, Hornby L, Lucar E, Bacon SL, et al
Reviewing Your Plan Documentation Your Blue Cross Blue Shield plan comes with a lot of paperwork, and somewhere in there is the information you need
If you have any questions about the use of this formulation, please do not hesitate to reach out for further information